Bell JL, Wachter K, Muhleck B, Pazaitis N, Kohn M, Lederer M, Huttelmaier S (2013) Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? Cell Mol Life Sci 70:2657–2675. https://doi.org/10.1007/s00018-012-1186-z

Article  CAS  PubMed  Google Scholar 

Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, Wigginton JM (2012) Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 366:2455–2465. https://doi.org/10.1056/NEJMoa1200694

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bravaccini S, Bronte G, Ulivi P (2021) TMB in NSCLC: a broken dream? Int J Mol Sci. https://doi.org/10.3390/ijms22126536

Article  PubMed  PubMed Central  Google Scholar 

Chen G, Huang AC, Zhang W, Zhang G, Wu M, Xu W, Guo W (2018) Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 560:382–386. https://doi.org/10.1038/s41586-018-0392-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen D, Guo W, Yu H, Yang J (2022) Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma. Transl Cancer Res 11:3064–3079. https://doi.org/10.21037/tcr-22-881

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elcheva IA, Wood T, Chiarolanzio K, Chim B, Wong M, Singh V, Spiegelman VS (2020) RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1. Leukemia 34:1354–1363. https://doi.org/10.1038/s41375-019-0656-9

Article  CAS  PubMed  Google Scholar 

Facchinetti F, Marabelle A, Rossi G, Soria JC, Besse B, Tiseo M (2016) Moving immune checkpoint blockade in thoracic tumors beyond NSCLC. J Thorac Oncol 11:1819–1836. https://doi.org/10.1016/j.jtho.2016.05.027

Article  PubMed  Google Scholar 

Galassi C, Musella M, Manduca N, Maccafeo E, Sistigu A (2021) The immune privilege of cancer stem cells: a key to understanding tumor immune escape and therapy failure. Cells. https://doi.org/10.3390/cells10092361

Article  PubMed  PubMed Central  Google Scholar 

Heng WS, Cheah SC (2020) Chelerythrine chloride downregulates beta-catenin and inhibits stem cell properties of non-small cell lung carcinoma. Molecules. https://doi.org/10.3390/molecules25010224

Article  PubMed  PubMed Central  Google Scholar 

Hong W, Xue M, Jiang J, Zhang Y, Gao X (2020) Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC). J Exp Clin Cancer Res 39:149. https://doi.org/10.1186/s13046-020-01648-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, Chen J (2018) Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol 20:285–295. https://doi.org/10.1038/s41556-018-0045-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiao PF, Tang PJ, Chu D, Li YM, Xu WH, Ren GF (2021) Long non-coding RNA THOR depletion inhibits human non-small cell lung cancer cell growth. Front Oncol. https://doi.org/10.3389/fonc.2021.756148

Article  PubMed  PubMed Central  Google Scholar 

Jiao CY, Feng QC, Li CX, Wang D, Han S, Zhang YD, Li XC (2021) BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK/c-Jun pathways. Cell Death Dis 12:63. https://doi.org/10.1038/s41419-020-03234-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jonna S, Subramaniam DS (2019) Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update. Discov Med 27:167–170

PubMed  Google Scholar 

Lastwika KJ, Wilson W III, Li QK, Norris J, Xu H, Ghazarian SR, Dennis PA (2016) Control of PD-L1 expression by oncogenic activation of the AKT-mTOR pathway in Non-Small Cell Lung Cancer. Cancer Res 76:227–238. https://doi.org/10.1158/0008-5472.CAN-14-3362

Article  CAS  PubMed  Google Scholar 

Liu Y, Guo X, Zhao M, Ao H, Leng X, Liu M, Zhu J (2020) Contributions and prognostic values of m(6) a RNA methylation regulators in non-small-cell lung cancer. J Cell Physiol 235:6043–6057. https://doi.org/10.1002/jcp.29531

Article  CAS  PubMed  Google Scholar 

Liu Y, Guo Q, Yang H, Zhang XW, Feng N, Wang JK, Tu PF (2022) Allosteric regulation of IGF2BP1 as a Novel Strategy for the activation of Tumor Immune Microenvironment. ACS Cent Sci 8:1102–1115. https://doi.org/10.1021/acscentsci.2c00107

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo F, Lin K (2022) N(6)-methyladenosine (m(6)A) reader IGF2BP1 accelerates gastric cancer aerobic glycolysis in c-Myc-dependent manner. Exp Cell Res 417:113176. https://doi.org/10.1016/j.yexcr.2022.113176

Article  CAS  PubMed  Google Scholar 

Mirza S, Vasaiya A, Vora H, Jain N, Rawal R (2017) Curcumin targets circulating Cancer Stem cells by inhibiting Self-Renewal Efficacy in Non-Small Cell Lung Carcinoma. Anticancer Agents Med Chem 17:859–864. https://doi.org/10.2174/1871520616666160923102549

Article  CAS  PubMed  Google Scholar 

Muller S, Bley N, Busch B, Glass M, Lederer M, Misiak C, Huttelmaier S (2020) The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer. Nucleic Acids Res 48:8576–8590. https://doi.org/10.1093/nar/gkaa653

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ni Z, Sun P, Zheng J, Wu M, Yang C, Cheng M, Li Y (2022) JNK Signaling promotes bladder Cancer Immune escape by regulating METTL3-Mediated m6A modification of PD-L1 mRNA. Cancer Res 82:1789–1802. https://doi.org/10.1158/0008-5472.CAN-21-1323

Article  CAS  PubMed  Google Scholar 

Osmani L, Askin F, Gabrielson E, Li QK (2018) Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): moving from targeted therapy to immunotherapy. Semin Cancer Biol 52:103–109. https://doi.org/10.1016/j.semcancer.2017.11.019

Article  CAS  PubMed  Google Scholar 

Pan S, Zhan Y, Chen X, Wu B, Liu B (2019) Identification of biomarkers for Controlling Cancer Stem Cell characteristics in bladder Cancer by Network Analysis of Transcriptome Data Stemness Indices. Front Oncol 9:613. https://doi.org/10.3389/fonc.2019.00613

Article  PubMed  PubMed Central  Google Scholar 

Raniszewska A, Vroman H, Dumoulin D, Cornelissen R, Aerts J, Domagala-Kulawik J (2021) PD-L1(+) lung cancer stem cells modify the metastatic lymph-node immunomicroenvironment in nsclc patients. Cancer Immunol Immunother 70:453–461. https://doi.org/10.1007/s00262-020-02648-y

Article  CAS  PubMed  Google Scholar 

Sekino Y, Han X, Kobayashi G, Babasaki T, Miyamoto S, Kobatake K, Matsubara A (2021) BUB1B overexpression is an independent prognostic marker and Associated with CD44, p53, and PD-L1 in renal cell carcinoma. Oncology 99:240–250. https://doi.org/10.1159/000512446

Article  CAS  PubMed  Google Scholar 

Song H, Li H, Ding X, Li M, Shen H, Li Y, Xing L (2020) Long noncoding RNA FEZF1AS1 facilitates nonsmall cell lung cancer progression via the ITGA11/miR516b5p axis. Int J Oncol 57:1333–1347. https://doi.org/10.3892/ijo.2020.5142

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sperling F, Misiak D, Huttelmaier S, Michl P, Griesmann H (2022) IGF2BP1 promotes proliferation of neuroendocrine neoplasms by post-transcriptional enhancement of EZH2. Cancers (Basel). https://doi.org/10.3390/cancers14092121

Article  PubMed  Google Scholar 

Sun D, Yang H, Fan L, Shen F, Wang Z (2021) m6A regulator-mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in severe asthma. J Cell Mol Med 25:10236–10247. https://doi.org/10.1111/jcmm.16961

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660

Article  PubMed  Google Scholar 

Toh TB, Lim JJ, Chow EK (2017) Epigenetics in cancer stem cells. Mol Cancer 16:29. https://doi.org/10.1186/s12943-017-0596-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (2015) Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, Thymus, and heart. J Thorac Oncol 10:1240–1242. https://doi.org/10.1097/JTO.0000000000000663

Article  PubMed  Google Scholar 

Tsuchiya H, Shiota G (2021) Immune evasion by cancer stem cells. Regen Ther 17:20–33. https://doi.org/10.1016/j.reth.2021.02.006

Article  CAS  PubMed